1-3 of 3
Siegfried Janz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma

Available to Purchase
Yijiang Shi, Fumou Sun, Yan Cheng, Brent Holmes, Binod Dhakal, Joseph F. Gera, Siegfried Janz, Alan Lichtenstein
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (4): 502–510.
https://doi.org/10.1158/1535-7163.MCT-21-0016
Published: 01 April 2022
View articletitled, Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma
Open the PDF for Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Abstract B38: Targeting FOXM1 in multiple myeloma

Free
Van S. Tompkins, Zhimin Gu, Hongwei Xu, Guido Tricot, Fenghuang Zhan, Siegfried Janz
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (5_Supplement): B38.
https://doi.org/10.1158/1535-7163.PMS-B38
Published: 01 May 2014
View articletitled, Abstract B38: Targeting FOXM1 in multiple myeloma
Journal Articles

Profiling Bortezomib Resistance Identifies Secondary Therapies in a Mouse Myeloma Model

Free
Holly A.F. Stessman, Linda B. Baughn, Aaron Sarver, Tian Xia, Raamesh Deshpande, Aatif Mansoor, Susan A. Walsh, John J. Sunderland, Nathan G. Dolloff, Michael A. Linden, Fenghuang Zhan, Siegfried Janz, Chad L. Myers, Brian G. Van Ness
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (6): 1140–1150.
https://doi.org/10.1158/1535-7163.MCT-12-1151
Published: 09 June 2013
View articletitled, Profiling Bortezomib Resistance Identifies Secondary Therapies in a Mouse Myeloma Model
Open the PDF for Profiling Bortezomib Resistance Identifies Secondary Therapies in a Mouse Myeloma Model in another window
Includes: Supplementary data